HIV & STI Department, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, United Kingdom.
HIV & STI Department, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, United Kingdom; Public Health Institute, Liverpool John Moores University, 2nd Floor Henry Cotton Campus, 15-21 Webster Street, Liverpool, L3 2ET, United Kingdom.
Int J Drug Policy. 2018 May;55:215-221. doi: 10.1016/j.drugpo.2018.02.017. Epub 2018 Mar 6.
Higher levels of drug use have been reported in lesbian, gay, bisexual and transgender (LGBT) communities, some of which can be explained by sexualised drug use, including 'chemsex'; the use of drugs before or during planned sexual activity to sustain, enhance, disinhibit or facilitate sex. We explored injecting and non-injecting drug use by sexual behaviour among people who inject drugs (PWID) in England, Wales and Northern Ireland.
Data were used from an unlinked-anonymous survey of PWID (2013-2016), where participants recruited through services self-completed a questionnaire. We included sexually active participants who had injected in the previous year, and compared injecting and non-injecting drug use between men reporting sex with men (MSM) and heterosexual men, and between women reporting sex with women (WSW) and heterosexual women. The questionnaire did not include GHB/GBL and methamphetamine use.
There were 299 MSM, 3215 heterosexual male, 122 WSW and 1336 heterosexual female participants. MSM were more likely than heterosexual men to use drugs associated with chemsex: injected or non-injected mephedrone (adjusted OR (AOR) 2.22, 95%CI 1.54-3.22; AOR 2.15, 95%CI 1.48-3.11) and injected or non-injected ketamine (AOR 1.98, 95%CI 1.29-3.05; AOR 2.57, 95%CI 1.59-4.15). MSM were also more likely to inject methadone, inhale solvents, take ecstasy, cocaine or speed. WSW were more likely than heterosexual women to use non-injected mephedrone (AOR 2.19, 95%CI 1.20-3.99) and use injected or non-injected ketamine (AOR 5.58, 95%CI 2.74-11.4; AOR 3.05, 95%CI 1.30-7.19). WSW were also more likely to inject methadone, inject cocaine, use non-injected cocaine, crack, benzodiazepines or ecstasy, inhale solvents, or smoke cannabis.
Injecting and non-injecting drug use differed between MSM/WSW and heterosexual men and women. The use of drugs that have been associated with chemsex and sexualised drug use is more common among both MSM and WSW than heterosexual men and women.
有研究报告称,女同性恋、男同性恋、双性恋和跨性别者(LGBT)群体中的药物使用水平较高,其中一些可以用性化药物使用来解释,包括“嗑药狂欢”;即在计划进行性行为之前或期间使用药物来维持、增强、抑制或促进性行为。我们在英格兰、威尔士和北爱尔兰的吸毒者中,调查了性活跃者的注射和非注射药物使用情况,这些性活跃者通过服务自行完成了问卷调查。我们纳入了在过去一年中进行过注射的性活跃参与者,并比较了报告与男性发生性关系(MSM)和异性恋男性的注射和非注射药物使用情况,以及报告与女性发生性关系(WSW)和异性恋女性的注射和非注射药物使用情况。调查问卷中不包括 GHB/GBL 和甲基苯丙胺的使用情况。
我们使用了 2013 年至 2016 年期间进行的一项未链接匿名吸毒者调查的数据,其中通过服务招募的参与者自行完成了一份问卷。我们纳入了进行过注射的性活跃参与者,并且比较了报告与男性发生性关系(MSM)和异性恋男性的注射和非注射药物使用情况,以及报告与女性发生性关系(WSW)和异性恋女性的注射和非注射药物使用情况。该问卷不包括 GHB/GBL 和甲基苯丙胺的使用情况。
有 299 名 MSM、3215 名异性恋男性、122 名 WSW 和 1336 名异性恋女性参与者。与异性恋男性相比,MSM 更有可能使用与嗑药狂欢相关的药物:注射或非注射的甲卡西酮(调整后的比值比(AOR)2.22,95%置信区间(CI)1.54-3.22;AOR 2.15,95%CI 1.48-3.11)和注射或非注射的氯胺酮(AOR 1.98,95%CI 1.29-3.05;AOR 2.57,95%CI 1.59-4.15)。MSM 也更有可能注射美沙酮、吸入溶剂、服用摇头丸、可卡因或冰毒。与异性恋女性相比,WSW 更有可能使用非注射的甲卡西酮(AOR 2.19,95%CI 1.20-3.99)和使用注射或非注射的氯胺酮(AOR 5.58,95%CI 2.74-11.4;AOR 3.05,95%CI 1.30-7.19)。WSW 也更有可能注射美沙酮、注射可卡因、使用非注射可卡因、快克、苯二氮䓬类或摇头丸、吸入溶剂或吸食大麻。
MSM/WSW 与异性恋男性和女性在注射和非注射药物使用方面存在差异。与异性恋男性和女性相比,MSM 和 WSW 更常使用与嗑药狂欢和性化药物使用相关的药物。